Funding for this research was provided by:
National Heart, Lung, and Blood Institute (R56HL128597)
Office of Academic Affiliations, Department of Veterans Affairs (BX000216)
Received: 10 August 2018
Accepted: 7 November 2018
First Online: 20 November 2018
Ethics approval and consent to participate
: All animal experiments were approved by the Institutional Animal Care and Use Committee of the University of Louisville, and the care and handling of the animals were in accordance with National Institutes of Health guidelines.
: Not applicable.
: Igor Zelko research is funded by National Institutes of Health. Jesse Roman serves or has served as investigator on industry-sponsored clinical trials related to pulmonary fibrosis (Gilead, Fibrogen, Intermune, Promedia, Novartis, Boehringer Ingelheim, and Bristol-Meyers-Squibb). He also served on the boards of the American Lung Association - Midland States, the Pulmonary Fibrosis Foundation, and the American Thoracic Society. His research is funded by the National Institutes of Health and the Department of Veterans Affairs. Jian Zhu has no competing interests to disclose.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.